MENU

Eureka projects

The development of a novel medicine for advanced prostate cancer
Cut-off: 
2
Ranking: 
42
Project ID: 
9386

A NOVEL HYALURONIC ACID-BASED GEL TO CONTROL BLEEDING DURING HIGH RISK SURGERY
Cut-off: 
6
Ranking: 
77
Project ID: 
10921

Development of CMTM6 inhibitors: Modulation of PDL1 for cancer treatment
Cut-off: 
8
Ranking: 
74
Project ID: 
11889

High yield cartilage cell isolation for commercially viable, single surgery knee cartilage repair

Development of a Bispecific therapeutic antibody for the treatment of metastatic breast cancer

Development of a fully human bispecific therapeutic antibody for T cell mediated eradication of Acute Myeloid Leukemia

Development of a balanced dual PI3K/mTOR kinase inhibitor: A new generation of potential drugs for targeted cancer therapy

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.